Harrow Health

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$63,742
$47,831
$66,831
$49,257
Gross Profit
47,512
32,307
52,696
37,239
EBITDA
16,307
-6,324
17,449
4,671
EBIT
11,403
-11,232
12,638
1,325
Net Income
4,995
-17,780
6,777
-4,220
Net Change In Cash
63,742
47,831
66,831
49,257
Free Cash Flow
-927
19,456
-55,339
2,428
Cash
52,963
66,726
47,247
72,601
Basic Shares
38,853
35,826
35,808
35,702

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$199,614
$130,193
$88,595
$72,476
Gross Profit
150,369
90,553
63,212
54,262
EBITDA
19,280
9,723
-3,102
4,259
EBIT
4,743
-2,617
-6,767
1,863
Net Income
-17,481
-24,411
-14,086
-18,007
Net Change In Cash
199,614
130,193
88,595
72,476
Cost of Revenue
54,103
37,866
Free Cash Flow
-60,876
-148,713
-6,068
-23,430
Cash
47,247
74,085
96,270
42,167
Basic Shares
35,651
32,617
27,460
26,757

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
$0.24
2025-03-31
-$0.38
2024-12-31
$0.40